We describe recent mobile health (mHealth) interventions supporting antiretroviral therapy (ART) medication adherence among HIV-positive MSM.
INTRODUCTION
Globally, gay, bisexual, and other MSM are disproportionately impacted by HIV [1,2 & ,3] . MSM are estimated to account for 18-49% of all new HIV infections worldwide [4] , with larger proportions in high-income countries such as the United States (67% of all new diagnoses in 2014) [5] . Treatment with antiretroviral therapy (ART) to achieve viral suppression improves individual health [6] and prevents onward transmission [7, 8 && ,9 && ,10]. Sustained adherence to ART is critical for long-term viral suppression but remains suboptimal among MSM, ranging from 16 to 74% across 12 countries [11] . In the United States, only half of all HIV-diagnosed MSM are estimated to achieve viral suppression [12] , with significantly lower rates documented among young MSM (6-7%) [13, 14] .
Societal stigma and discrimination within healthcare systems impede access to quality HIV care for MSM and influence adherence and viral suppression [15] [16] [17] . Many MSM manage multiple adherence barriers (e.g., mental health and unstable housing) [16, 18, 19] , with each factor increasing the chances of having a detectable viral load [16, 20 && ]. Despite clear need, few ART adherence interventions have focused explicitly on MSM [21 ] . The flexibility of mHealth interventions allows the delivery of tailored content for each user's needs [23] and accessibility helps reduce some societal and structural barriers [26] . mHealth also offers strong capability for scalability and diffusion across geographic locations, including within resource-limited settings 
METHODS
We searched PubMed from 1 January 2016 to 13 May 2017 for English language publications, using combinations of keywords and MeSH terms: HIV, AIDS, antiretroviral, ART, therapy, medication, adherence, compliance, nonadheren Ã , technology, technology-based, SMS, text messag Ã , texting, online, internet, web, Web 2.0, social media, social networking, app Ã , application Ã , smartphone Ã , cell phone Ã , cellular phone Ã , mobile phone Ã , eHealth, mHealth, video conferenc Ã , videoconferenc Ã , Twitter, Grindr, Jack'd, Facebook, computeriz Ã , computer-based, virtual reality, VR, MSM, men who have sex with men, gay, homosexual, bisexual, LGBT Ã , sexual minorit Ã . Publications were excluded that did not include: an intervention description, an mHealth intervention component, an ART adherence behavioral (e.g., self-reported medication taking, device recorded medication taking) or biomedical (e.g., viral load, viral suppression, and drug levels) outcome, or a focus on MSM populations or report including MSM subpopulations. Three authors reviewed citations and full texts were pulled for all citations noted as relevant by at least one reviewer. Of the 721 articles extracted, seven articles reporting on six interventions met inclusion criteria (Table 1) .
RECENT ANTIRETROVIRAL THERAPY MOBILE HEALTH ADHERENCE INTERVENTIONS TAILORED FOR OR INCLUSIVE OF MSM
For core mHealth components, most interventions used text messaging, including three pilot studies, one randomized controlled trial (RCT) [ 
KEY POINTS
Recent mHealth intervention tools to support HIV medication adherence among MSM show acceptability, feasibility, and preliminary efficacy at increasing ART use intentions, self-reported adherence, and viral suppression.
Additional research is needed in the form of rigorous large-scale trials, evaluation of commercially available medication adherence apps, and development of new methods to accurately measure adherence and assess which clinically relevant barriers can be addressed using technology-based tools.
Further development needs for technology-based adherence interventions include end-user engagement features, tools for coordinating patient and provider adherence data (e.g., dashboards), and adaptation of efficacious interventions for new languages and geographic settings. States who were either new to care, had experienced a break in care of a year or more, or who were considered by their provider to be at-risk for ART or appointment nonadherence (14/32 had detectable viral load at baseline, 13/32 identified as MSM). Participants received 6 months of SMS about adherence and HIV care. At enrollment, participants were prompted to identify their own barriers and facilitators to care or choose from preselected barriers and facilitators adapted from the US CDC's Medical Monitoring Project. Study staff called once per month to discuss and adjust (if needed) frequency and content of SMS. Comparing baseline to followup, the proportion of virally suppressed participants increased from 56 to 78% (P ¼ 0.002).
The second intervention, by Senn et al., ] of a text messaging and peersupport intervention to improve retention in care and adherence for Black MSM in the United States. Peer mentors -themselves HIV-positive Black MSM -received a 2-h training on information and skills related to ART and HIV care and how to respond to participants ('mentees') in nonjudgmental, motivational ways. Participants were assisted in sending their first message to peer mentors at study enrollment. For 1 month, mentors communicated with mentees via SMS. Mentors were asked to respond to texts within 12 h and to make contact with mentees at least every 3 days. Five out of seven participants were satisfied/very satisfied with the intervention. Mentees wanted more frequent contact, whereas both mentors and mentees wanted more personalized contact (e.g., an introductory phone call 
Thus, there is interest, public health need, and scientific rationale for multicomponent, complex mHealth interventions to support ART adherence among MSM. Interventions should be responsive to current best practices for mHealth-supported ART adherence and tailored to men's expressed needs and preferences. Intervention developers may want to consider incorporating gamification to improve engagement [45, 46] and dynamic tailoring based on frequent assessments -features that effectively promote ART adherence [30, 47] . Several interventions are underway that do this for MSM. Thrive with Me is a theoretically based (IMB model), multicomponent ART adherence intervention for MSM age 18 years and older (majority substance users) that includes asynchronous peer communication (similar to Facebook), tailored adherence information, and SMS dose reminders, and SMS adherence, mood, and substance use self-monitoring. An 8-week pilot study showed high feasibility (90%), acceptability, and significant improvement in self-reported ART adherence [48] , and the intervention is currently undergoing an RCT in New York City [49] . AllyQuest is an HIV medication adherence and social support app [for Android and iPhone (Apple Inc., Foxconn, Pegatron, Cupertino, California, USA)] designed for MSM age 18-29 years. The app components were informed by SCT and the Fogg Behavioral Model [50] of persuasive technology. In a 4-week pilot study, greater app use was associated with significant increases in knowledge about HIV and confidence in ability to reliably take ART [51] . & ,60]) may offer new venues in this regard. Furthermore, whereas mHealth may facilitate more frequent recording of adherence, at least one study to date found discordance between app-measured adherence and self-report and pharmacy refill, with app-measured adherence being lower [61] . This will be the case if participants do not use the app every day, emphasizing the importance of creating highly engaging apps, considering whether users should be able to back-fill app-based adherence data, including biological outcome measures (viral load), and identifying parameter estimates for adjusting app-reported data. At least two studies in the field are currently gathering these metrics [25 && ,49]. Third, as mHealth interventions become more complex, individually tailored, and multifeature, the complexity of measuring meaningful or standardized intervention exposure/dose also becomes more complicated. Extremely limited work has been done in this area for HIV interventions (Bauermeister et al., current issue), hampering the ability to identify which intervention components and features are associated with desired outcomes.
Relatedly, the chronicity of HIV raises questions about the use of mHealth to maintain longer term ART adherence beyond a typical 3-12-month intervention period. Extended utility would require resources and innovation to create content and features that are continually new, relevant, and aligned with the evolving evidence base. Further challenges stem from the need to keep up with software and hardware upgrades. The use of opensource software and existing platforms that also evolve over time and the adaptation of existing platforms for new populations can mitigate some of these resource demands. Effective, open-source interventions could also be embedded into commercial platforms (e.g., Apple Health) to maximize uptake. On the side of scientific rigor, there are unanswered questions about whether people actually need to use mHealth tools for long periods of time -or whether the tools can establish selfsustaining skills and patterned behaviors. Furthermore, in trials, participants are asked to use (or be exposed to) mHealth interventions continuously over a set amount of time. However, in real-world settings, some of these interventions may be better employed in an 'as needed' fashion. Implementation studies and dynamic intervention designs (e.g., Sequential Multiple Assignment Randomized Trials) may offer insight by providing data about long-term mHealth use and effectiveness and testing combinations of mHealth intervention approaches.
Perhaps the greatest area for growth in mHealth interventions for MSM is the exchange of evidencebased mHealth interventions or intervention components across settings and populations. This includes the tailoring and testing of effective general population mHealth interventions for use with MSM, as well as the cultural adaptation and translation to other languages of successful MSM-focused apps, SMS-based interventions, and social media approaches.
CONCLUSION
Several recent mHealth interventions developed specifically for MSM show promise for supporting ART adherence and viral suppression. However, none of the reviewed interventions for MSM measured the impact of an mHealth intervention on viral suppression compared with a control condition. Several studies are planned or underway that will assess multiple features within complex smartphone or internet-based platforms providing the opportunity to advance the evidence base for mHealth supported ART adherence as well as expand the science in mHealth measurement and engagement challenges. Combination interventions that use multiple delivery modalities are a future important area for growth alongside adapting efficacious interventions for new languages and geographic settings. Global saturation of basic phones -and increasingly smartphones -has laid the groundwork for widely scalable mHealth interventions to support ART adherence to achieve viral suppression among significantly more HIV-positive MSM. Presents the design, development, and usability testing of Epic Allies -an MSMtailored app based on information motivation and behavioral skills (IMB) theory and utilizing game mechanics, social networking features, personalization, tailored feedback messages, functional ART support (e.g., editable medication alarm, daily medication tracker), and privacy features. Participants preferred an adherence app that was informational, interactive, social, and customizable. In usability testing, the app was easy to understand and navigate, and was rated highly. This intervention is currently being tested in a US-based five-site randomized controlled trial (RCT). Reports on a pilot study conducted among 32 people living with HIV (including 13 MSM). Participants received daily two-way SMS for 6 months on topics like ART adherence, care appointments, and barriers to staying in care. User queries were answered by SMS or call within 24-48 h. Monthly calls were used to adjust frequency and content of SMS based on user preference. Viral suppression increased baseline to 6-month follow-up from 56 to 78% (P ¼ 0.002, no control group). Reports on the design, development, and pilot testing of a two-way SMS app (for Android phones) and peer support for HIV-positive Black MSM who have missed an HIV appointment, experienced a break in care or report being less than 95% ART adherent. For 1 month, mentors provide via SMS informational and motivational support about HIV; help mentees build skills to stay in care and take ART (based on IMB). Mentors' protocol: respond to texts within 12 h; contact at least every 3 days. The pilot was conducted with three mentors and eight mentees. The intervention was feasible and acceptable: 5/7 were satisfied/very satisfied. Mentees wanted more frequent contact; mentors and mentees wanted more personalized contact (e.g., introductory phone call). Social media was recommended as additional contact. No HIV care outcomes are reported. Describes the design and development of weCare -a health educator guided intervention for racially and ethnically diverse MSM age 13-34 years that will utilize participants' existing social media preferences (Facebook, in-app instant messenger) and SMS to support the full HIV Continuum of Care from prevention to treatment. weCare was developed using CBPR methods, based on social cognitive theory (SCT) and theory of empowerment education. The adherencefocused components include ART refill and daily medication reminders, problem solving for ART prescription and adherence barriers, and positive reinforcement of desired behaviors. An implementation and evaluation trial was planned to start in late 2016. This internet-based and phone-based RCT aims to reduce sexually transmitted infections and condomless anal intercourse among HIV-positive MSM in the United States. The intervention also includes a focus on HIV-status disclosure. For 12 months, participants received either a monthly internet-based sexual behavior survey, or the same monthly survey and tailored SMS focused on personalized (algorithm-based) risk-reduction. Increase in disclosure and decrease in sexual risk was found in both study arms without significant differences. 
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& Kalichman SC, Kalichman MO, Cherry C. Forget about forgetting: structural barriers and severe nonadherence to antiretroviral therapy. AIDS Care 2017; 29:418-422. This study analyses data from 556 people living with HIV with lower than 95% ART adherence. Analysis then classified participants as 'severely nonadherent' (less than 75% ART) and 'moderately nonadherent' (75-95% ART) and compared reasons for nonadherence. Severe nonadherence was significantly associated with substance use and other structural barriers (e.g., cost of medication). The authors conclude that reminders/memory aids alone will not be enough to overcome severe nonadherence in similar populations as that studied. 58. 
